{"entity":{"type":"insider","cik":"0001701247","url":"/insider/0001701247","json_url":"/insider/0001701247.json","name":"Collins Helen Louise","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":11,"first":"2024-04-15","last":"2026-08-19","span_basis":"filed_date"},"name_variants":[{"name":"Collins Helen Louise","source":"filing","n_filings":11,"first_seen":"2024-04-15","last_seen":"2026-08-19"}],"transactions":[{"id":9298294,"accession":"0001701247-26-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001701247-26-000012","line_url":"/filing/0001701247-26-000012","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001701247","owner_name":"Collins Helen Louise","owner_display_name":"Collins Helen Louise","owner_url":"/insider/0001701247","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":58.586156,"price_display":"58.59","price_state":"stated","total_value":292930.78,"total_display":"292,930.78","total_whole":"292,931","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"insider","n_lines":2},{"id":6045759,"accession":"0001701247-26-000011","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001701247-26-000011","line_url":"/filing/0001701247-26-000011","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001701247","owner_name":"Collins Helen Louise","owner_display_name":"Collins Helen Louise","owner_url":"/insider/0001701247","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":52.67467678,"price_display":"52.67","price_state":"stated","total_value":263373.3839,"total_display":"263,373.38","total_whole":"263,373","shares_owned_after":25063.0,"shares_owned_after_display":"25,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-17","filed_date":"2026-07-21","scope":"insider","n_lines":5},{"id":5767259,"accession":"0001701247-26-000010","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001701247-26-000010","line_url":"/filing/0001701247-26-000010","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001701247","owner_name":"Collins Helen Louise","owner_display_name":"Collins Helen Louise","owner_url":"/insider/0001701247","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":43.80336898,"price_display":"43.80","price_state":"stated","total_value":219016.8449,"total_display":"219,016.84","total_whole":"219,017","shares_owned_after":26133.0,"shares_owned_after_display":"26,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-17","filed_date":"2026-06-22","scope":"insider","n_lines":3},{"id":5910651,"accession":"0001701247-26-000007","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001701247-26-000007","line_url":"/filing/0001701247-26-000007","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001701247","owner_name":"Collins Helen Louise","owner_display_name":"Collins Helen Louise","owner_url":"/insider/0001701247","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":39.79427884,"price_display":"39.79","price_state":"stated","total_value":198971.3942,"total_display":"198,971.39","total_whole":"198,971","shares_owned_after":26525.0,"shares_owned_after_display":"26,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-20","scope":"insider","n_lines":3},{"id":6045743,"accession":"0001701247-26-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001701247-26-000006","line_url":"/filing/0001701247-26-000006","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001701247","owner_name":"Collins Helen Louise","owner_display_name":"Collins Helen Louise","owner_url":"/insider/0001701247","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":47.67048318,"price_display":"47.67","price_state":"stated","total_value":238352.4159,"total_display":"238,352.42","total_whole":"238,352","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-17","filed_date":"2026-04-21","scope":"insider","n_lines":3},{"id":5840493,"accession":"0001701247-26-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001701247-26-000005","line_url":"/filing/0001701247-26-000005#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001701247","owner_name":"Collins Helen Louise","owner_display_name":"Collins Helen Louise","owner_url":"/insider/0001701247","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":35.1006,"price_display":"35.10","price_state":"stated","total_value":1404024.0,"total_display":"1,404,024.00","total_whole":"1,404,024","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-25","filed_date":"2026-03-27","scope":"insider"},{"id":5746890,"accession":"0001701247-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001701247-26-000004","line_url":"/filing/0001701247-26-000004#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001701247","owner_name":"Collins Helen Louise","owner_display_name":"Collins Helen Louise","owner_url":"/insider/0001701247","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":27.76,"price_display":"27.76","price_state":"stated","total_value":138800.0,"total_display":"138,800.00","total_whole":"138,800","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-19","scope":"insider"},{"id":5968415,"accession":"0001701247-26-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001701247-26-000003","line_url":"/filing/0001701247-26-000003#line-4","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001701247","owner_name":"Collins Helen Louise","owner_display_name":"Collins Helen Louise","owner_url":"/insider/0001701247","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10129.0,"shares_display":"10,129","price_per_share":30.1932,"price_display":"30.19","price_state":"stated","total_value":305826.9228,"total_display":"305,826.92","total_whole":"305,827","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-10","filed_date":"2026-03-11","scope":"insider"},{"id":5968411,"accession":"0001701247-26-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001701247-26-000003","line_url":"/filing/0001701247-26-000003#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001701247","owner_name":"Collins Helen Louise","owner_display_name":"Collins Helen Louise","owner_url":"/insider/0001701247","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29871.0,"shares_display":"29,871","price_per_share":30.0228,"price_display":"30.02","price_state":"stated","total_value":896811.0588,"total_display":"896,811.06","total_whole":"896,811","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-09","filed_date":"2026-03-11","scope":"insider"},{"id":6198864,"accession":"0001701247-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001701247-26-000002","line_url":"/filing/0001701247-26-000002#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001701247","owner_name":"Collins Helen Louise","owner_display_name":"Collins Helen Louise","owner_url":"/insider/0001701247","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":26.1747,"price_display":"26.17","price_state":"stated","total_value":1177861.5,"total_display":"1,177,861.50","total_whole":"1,177,862","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-19","scope":"insider"},{"id":2044228,"accession":"0001415889-24-025499","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-025499","line_url":"/filing/0001415889-24-025499#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001701247","owner_name":"Collins Helen Louise","owner_display_name":"Collins Helen Louise","owner_url":"/insider/0001701247","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":816.0,"shares_display":"816","price_per_share":30.003,"price_display":"30.00","price_state":"stated","total_value":24482.448,"total_display":"24,482.45","total_whole":"24,482","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-22","scope":"insider"},{"id":2329632,"accession":"0001415889-24-010823","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-010823","line_url":"/filing/0001415889-24-010823#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001701247","owner_name":"Collins Helen Louise","owner_display_name":"Collins Helen Louise","owner_url":"/insider/0001701247","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":25.0739,"price_display":"25.07","price_state":"stated","total_value":501478.0,"total_display":"501,478.00","total_whole":"501,478","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-11","filed_date":"2024-04-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001672619","name":"Enliven Therapeutics, Inc.","url":"/issuer/0001672619","role":"Officer (CHIEF MEDICAL OFFICER)","n_filings":11,"first_seen":"2024-04-15","last_seen":"2026-08-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001701247","retrieved_at":"2026-08-25T21:57:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}